论文部分内容阅读
回顾性分析埋藏式心脏转复除颤器(ICD)治疗患者中心房颤动(AF)的发生率,评价AF对ICD治疗患者再次住院、不适当放电治疗和总死亡率的影响。182例ICD置入患者,随访48±17个月,用存活率回归分析等相关统计方法,对AF组和窦律(SR)组再住院率、不适当放电治疗和总死亡率等进行比较。结果:两组在室性心律失常再发生率和再住院率上无明显差异(P>0.05)。存活率分析,AF组患者较SR组患者低(P=0.038)。ICD治疗患者,新的AF发生率为8.43%。在AF组中,ICD治疗前有AF病史的患者其不适当放电治疗发生率为25%,而新出现AF病史的患者,不适当放电治疗发生率为64.3%(P<0.05)。结论:ICD治疗后,新发现的AF患者有更高的不适当放电治疗危险。有AF病史的患者,3年存活率比一直为窦性节律的患者低。
The incidence of atrial fibrillation (AF) in patients undergoing implanted cardioverter defibrillators (ICD) was retrospectively analyzed, and the effect of AF on rehospitalization, improper discharge therapy and overall mortality in ICD patients was evaluated. A total of 182 ICD patients were followed up for 48 ± 17 months. The survival rate of the ICR was compared with the rehospitalization rate, inappropriate discharge rate and total mortality in the AF group and the sinus rhythm group. Results: There was no significant difference in the incidence of recurrent ventricular arrhythmias and rehospitalization between the two groups (P> 0.05). Survival analysis showed that patients in the AF group were lower than those in the SR group (P = 0.038). ICD treatment of patients, the new incidence of AF was 8.43%. In the AF group, the incidence of inappropriate discharge was 25% in patients with an AF prior to ICD and 64.3% in patients with newly developed AF (64.3%). Conclusions: Newly discovered AF patients have a higher risk of inappropriate discharge after ICD treatment. Patients with a history of AF have a 3-year survival rate lower than those who have been sinus rhythm.